Workflow
Phase III Clinical Updates
icon
Search documents
Daiichi Sankyo Company, Limited (DSNKY) Discusses Oncology Pipeline Advances and Phase III Clinical Updates at Science and Technology Day Transcript
Seeking Alphaยท 2025-12-16 10:30
Group 1 - The event is Daiichi Sankyo's Science and Technology Day 2025, moderated by Kentaro Asakura, Corporate Officer and Head of Corporate Communications [1] - The briefing will be conducted in Japanese and English, with simultaneous interpretation available for participants [2] - Key speakers include Okuzawa (President and CEO), Takeshita (Head of Global R&D), Ken Keller (Director and Head of Global Oncology business), Kashiwase (Head of Global Technology), and Abe (Head of Global) [3]